60% of US adults are vaccinated against COVID-19

Amy Baxter | | Health Exec | COVID-19
COVID-19 vaccines help reduce the serious coronavirus infections and hospitalizations. Multiple studies have shown that the risk from very rare vaccine side effects are far outweighed by the much greater risk of hospitalization and death due to COVID infections.

New data shows 60% of U.S. adults are vaccinated against COVID-19.

The figures come with less than two months to President Biden’s goal for 70% of adults to be vaccinated by July 4. In addition, the number of new COVID-19 cases has dropped to 31,200 on a seven-day average, CNBC reported. In April, the new case daily count averaged more than 71,000.

Among those who have received vaccines, about 48% of the population has received one dose, while 38% are fully vaccinated. Nearly 2 million vaccines are being distributed daily over the past week. That’s down from a peak of vaccine distribution during April. However, the U.S. is still reporting 614 COVID-19 deaths per day, and more than 587,000 deaths have occurred. 

In addition, the Centers for Disease Control and Prevention has opened up vaccinations to children ages 12 to 15. More than 600,000 children have been vaccinated as of May 18.

 

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Monitoring acute heart patients at home linked to considerable cost savings
Brazen marital healthcare scheme ends with guilty pleas
CityMD agrees to $12M settlement over alleged COVID claims fraud
Q&A: Cardiologist Karen Joynt Maddox on why new healthcare policies are not improving outcomes
Does Covid-19 raise risk for cancers—including rare ones?
FDA panel recommends new COVID-19 booster

Around the web

Cardiovascular Business
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”